Revolution Medicines Inc (NAS:RVMD)
$ 58.58 -0.05 (-0.09%) Market Cap: 9.85 Bil Enterprise Value: 8.39 Bil PE Ratio: 0 PB Ratio: 6.27 GF Score: 43/100

Q1 2023 Revolution Medicines Inc Earnings Call Transcript

May 08, 2023 / 08:30PM GMT
Release Date Price: $24.44 (+0.41%)
Operator

Good day, and welcome to Revolution Medicine's First Quarter 2023 Earnings Conference Call. (Operator Instructions) As a reminder, today's conference is being recorded.

I would now like to turn the conference over to your host, Erin Graves, Senior Director of Corporate Communications and Investor Relations. Erin, please go ahead.

Unidentified Analyst

Thank you, and welcome, everyone, to the First Quarter 2023 earnings call. Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicine's Chairman and Chief Executive Officer; Dr. Steve Kelsey, our President of R&D; and Jack Anders, our Chief Financial Officer. Peg Horn, our Chief Operating Officer, will also join us for the Q&A portion of today's call.

As we begin, I would like to note that our presentation will include statements regarding the current beliefs of the company with respect to our business that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act. These statements are subject to a number of assumptions, risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot